BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 20453069)

  • 1. Factors at admission associated with bleeding risk in medical patients: findings from the IMPROVE investigators.
    Decousus H; Tapson VF; Bergmann JF; Chong BH; Froehlich JB; Kakkar AK; Merli GJ; Monreal M; Nakamura M; Pavanello R; Pini M; Piovella F; Spencer FA; Spyropoulos AC; Turpie AG; Zotz RB; Fitzgerald G; Anderson FA;
    Chest; 2011 Jan; 139(1):69-79. PubMed ID: 20453069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of the International Medical Prevention Registry on Venous Thromboembolism Bleeding Risk Score.
    Hostler DC; Marx ES; Moores LK; Petteys SK; Hostler JM; Mitchell JD; Holley PR; Collen JF; Foster BE; Holley AB
    Chest; 2016 Feb; 149(2):372-9. PubMed ID: 26867833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. External validation of the risk assessment model of the International Medical Prevention Registry on Venous Thromboembolism (IMPROVE) for medical patients in a tertiary health system.
    Rosenberg D; Eichorn A; Alarcon M; McCullagh L; McGinn T; Spyropoulos AC
    J Am Heart Assoc; 2014 Nov; 3(6):e001152. PubMed ID: 25404191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can we IMPROVE bleeding risk assessment for acutely ill, hospitalized medical patients?
    Tay KH; Lip GY; Lane DA
    Chest; 2011 Jan; 139(1):10-3. PubMed ID: 21208874
    [No Abstract]   [Full Text] [Related]  

  • 5. Venous thromboembolism prophylaxis in acutely ill hospitalized medical patients: findings from the International Medical Prevention Registry on Venous Thromboembolism.
    Tapson VF; Decousus H; Pini M; Chong BH; Froehlich JB; Monreal M; Spyropoulos AC; Merli GJ; Zotz RB; Bergmann JF; Pavanello R; Turpie AG; Nakamura M; Piovella F; Kakkar AK; Spencer FA; Fitzgerald G; Anderson FA;
    Chest; 2007 Sep; 132(3):936-45. PubMed ID: 17573514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Venous thromboembolism risk and prophylaxis in hospitalised medically ill patients. The ENDORSE Global Survey.
    Bergmann JF; Cohen AT; Tapson VF; Goldhaber SZ; Kakkar AK; Deslandes B; Huang W; Anderson FA;
    Thromb Haemost; 2010 Apr; 103(4):736-48. PubMed ID: 20135072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bleeding and venous thromboembolism arising in acutely ill hospitalized medical patients. Findings from the Spanish national discharge database.
    Guijarro R; San Roman C; Arcelus JI; Montes-Santiago J; Gómez-Huelgas R; Gallardo P; Monreal M
    Eur J Intern Med; 2014 Feb; 25(2):137-41. PubMed ID: 24200547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety of fondaparinux in the prevention of venous thromboembolism in elderly medical patients: results of a single-center, retrospective study.
    Silvestri F; Pasca S; Labombarda A; Barbi A; Desideri M; Guidi P; Rogato A; Zaramella M; Bergamo M; Ageno W; Barillari G
    Minerva Med; 2014 Jun; 105(3):221-8. PubMed ID: 24988087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival effects of inferior vena cava filter in patients with acute symptomatic venous thromboembolism and a significant bleeding risk.
    Muriel A; Jiménez D; Aujesky D; Bertoletti L; Decousus H; Laporte S; Mismetti P; Muñoz FJ; Yusen R; Monreal M;
    J Am Coll Cardiol; 2014 Apr; 63(16):1675-83. PubMed ID: 24576432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Duration of venous thromboembolism risk across a continuum in medically ill hospitalized patients.
    Amin AN; Varker H; Princic N; Lin J; Thompson S; Johnston S
    J Hosp Med; 2012 Mar; 7(3):231-8. PubMed ID: 22190427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of hemorrhage in patients with chronic liver disease and coagulopathy receiving pharmacologic venous thromboembolism prophylaxis.
    Reichert JA; Hlavinka PF; Stolzfus JC
    Pharmacotherapy; 2014 Oct; 34(10):1043-9. PubMed ID: 25052037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Venous thromboembolism following primary total hip arthroplasty.
    Hitos K; Fletcher JP
    Int Angiol; 2009 Jun; 28(3):215-21. PubMed ID: 19506541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prophylaxis against venous thromboembolism in hospitalized medically ill patients.
    Pendergraft T; Liu X; Edelsberg J; Phatak H; Vera-Llonch M; Liu LZ; Oster G
    Circ Cardiovasc Qual Outcomes; 2013 Jan; 6(1):75-82. PubMed ID: 23300270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of pharmacologic prophylaxis for venous thromboembolism in patients with chronic liver disease.
    Barclay SM; Jeffres MN; Nguyen K; Nguyen T
    Pharmacotherapy; 2013 Apr; 33(4):375-82. PubMed ID: 23553808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicenter evaluation of the use of venous thromboembolism prophylaxis in acutely ill medical patients in Canada.
    Kahn SR; Panju A; Geerts W; Pineo GF; Desjardins L; Turpie AG; Glezer S; Thabane L; Sebaldt RJ;
    Thromb Res; 2007; 119(2):145-55. PubMed ID: 16516275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive and associative models to identify hospitalized medical patients at risk for VTE.
    Spyropoulos AC; Anderson FA; FitzGerald G; Decousus H; Pini M; Chong BH; Zotz RB; Bergmann JF; Tapson V; Froehlich JB; Monreal M; Merli GJ; Pavanello R; Turpie AGG; Nakamura M; Piovella F; Kakkar AK; Spencer FA;
    Chest; 2011 Sep; 140(3):706-714. PubMed ID: 21436241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retrospective evaluation of venous thromboembolism prophylaxis in the adult cancer population.
    Reeves D; Liu CY
    J Oncol Pharm Pract; 2010 Mar; 16(1):27-31. PubMed ID: 19401307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Venous thromboembolism prophylaxis in acutely ill hospitalized medical patients. A retrospective multicenter study.
    Nieto JA; Cámara T; Camacho I;
    Eur J Intern Med; 2014 Oct; 25(8):717-23. PubMed ID: 25091470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In-hospital major bleeding during ST-elevation and non-ST-elevation myocardial infarction care: derivation and validation of a model from the ACTION Registry®-GWTG™.
    Mathews R; Peterson ED; Chen AY; Wang TY; Chin CT; Fonarow GC; Cannon CP; Rumsfeld JS; Roe MT; Alexander KP
    Am J Cardiol; 2011 Apr; 107(8):1136-43. PubMed ID: 21324428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inadequate venous thromboembolism risk stratification predicts venous thromboembolic events in surgical intensive care unit patients.
    Pannucci CJ; Obi A; Alvarez R; Abdullah N; Nackashi A; Hu HM; Bahl V; Henke PK
    J Am Coll Surg; 2014 May; 218(5):898-904. PubMed ID: 24680577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.